Accelerate your study timeline through our direct-to-patient network
Sanguine has developed a network of 20,000 patients, including 50+ patient advocacy group non-profits, biobanks, and patient portals. Through our direct-to-patient platform, we can dramatically hasten the completion of your study. Download our case studies to learn more about how we can help:
- How can we accelerate your study timeline? We have an expansive patient network, quick turnaround, and high-touch patient engagement methods.
- 90+% Recall Rate: Our direct relationships with patients allow us to recontact them for subsequent sampling studies, including clinical trials.
- Higher Quality Data: We aggregate the patient’s EMR, as well as self-reported information, and most biospecimen samples.
A list of our data and specimen used in 40+ peer-reviewed journal articles:
- Nature
- Journal of Immunology
- Journal of Virology
- American Society of Microbiology
- Journal of Biological Chemistry
- Science
Already have a study in mind? Contact us today at 818.462.8290 to work together